HealthDay News — Diagnoses of early prostate cancer continue to decline in the United States, following the US Preventive Services Task Force recommendation against routine screening, according to a research letter published online in JAMA Oncology.
Using the Surveillance, Epidemiology, and End Results database, Ahmedin Jemal, PhD, vice president of the American Cancer Society’s surveillance and health services research program, and colleagues looked at cases of prostate cancer diagnosed between 2005 and 2013 in men aged 50 and older.
The authors found that from 2012 to 2013, early prostate cancer diagnosis rates per 100,000 men dropped from 356.5 to 335.4 in men aged 50 to 74. In men older than that, early cancer diagnoses fell from 379.2 to 353.6 per 100,000 men. Meanwhile, cases of advanced prostate cancer remained stable in both age groups.
“Whether this pattern will lead to a future increase in the diagnosis of distant-stage disease and prostate cancer mortality requires long-term monitoring because of the slow-growing nature of this malignant neoplasm,” the authors write.
- Jemal A, Ma J, Siegel R, et al. Prostate Cancer Incidence Rates 2 Years After the US Preventive Task Force Recommendations Against Screening. JAMA Oncol. 2016; doi: 10.1001/jamaoncol.2016.2667.